Trial Profile
Effects of ezetimibe on visceral fat in patients with metabolic syndrome: a randomized controlled study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hypercholesterolaemia; Insulin resistance; Metabolic syndrome; Obesity
- Focus Pharmacodynamics
- 01 Dec 2012 Results published in the European Journal of Clinical Investigation.
- 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.
- 03 Aug 2012 New trial record